Authors:
Wolfe, F
Lassere, M
van der Heijde, D
Stucki, G
Suarez-Almazor, M
Pincus, T
Eberhardt, K
Kvien, TK
Symmons, D
Silman, A
van Riel, P
Tugwell, P
Boers, M
Citation: F. Wolfe et al., Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology, J RHEUMATOL, 26(2), 1999, pp. 484-489
Authors:
Brekke, M
Hjortdahl, P
Thelle, DS
Kvien, TK
Citation: M. Brekke et al., Disease activity and severity in patients with rheumatoid arthritis: relations to socioeconomic inequality, SOCIAL SC M, 48(12), 1999, pp. 1743-1750
Authors:
Emery, P
Zeidler, H
Kvien, TK
Guslandi, M
Naudin, R
Stead, H
Verburg, KM
Isakson, PC
Hubbard, RC
Geis, GS
Citation: P. Emery et al., Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison, LANCET, 354(9196), 1999, pp. 2106-2111
Authors:
Smolen, JS
Kalden, JR
Scott, DL
Rozman, B
Kvien, TK
Larsen, A
Loew-Friedrich, I
Oed, C
Rosenburg, R
Citation: Js. Smolen et al., Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial, LANCET, 353(9149), 1999, pp. 259-266
Citation: Is. Kristiansen et al., Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis, ARTH RHEUM, 42(11), 1999, pp. 2293-2302
Citation: T. Uhlig et al., Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis, ANN RHEUM D, 58(7), 1999, pp. 415-422